Últimas noticias sobre 10x Genomics (NASDAQ:TXG) Bolsa

10X GENOMICS INC-CLASS A

10x Genomics

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Equities

News

ETFs

ACHR

ARKK

PLTR

QCOM

RBLX

Ark Invest vendió acciones de Palantir por 10,4M$. ¿Qué impulsó esta decisión y qué significa para los inversionistas?

Ark Invest ajusta su portafolio: venta masiva de Palantir y nuevas compras estratégicas

10x Genomics Inc

TEXAS GULF ENERGY INC by Texas Gulf Energy, Incorporated.

Texas Gulf Energy Inc

Wells Fargo analyst Michael Brown maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Overweight and lowers the price target from $93 to $87.

Price Target

Analyst Ratings

SCHW

Wells Fargo Maintains Overweight on Charles Schwab, Lowers Price Target to $87

Wells Fargo analyst Michael Brown maintains Stifel Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SF#NYSE">SF</a>) with a Overweight and lowers the price target from $135 to $106.

Wells Fargo Maintains Overweight on Stifel Financial, Lowers Price Target to $106

Wells Fargo analyst Michael Brown maintains Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) with a Equal-Weight and lowers the price target from $176 to $143.

Wells Fargo Maintains Equal-Weight on Raymond James Finl, Lowers Price Target to $143

Wells Fargo analyst Michael Brown maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Equal-Weight and lowers the price target from $63 to $55.

Wells Fargo Maintains Equal-Weight on Moelis, Lowers Price Target to $55

Wells Fargo analyst Michael Brown maintains LPL Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>) with a Overweight and lowers the price target from $405 to $342.

LPLA

Wells Fargo Maintains Overweight on LPL Finl Hldgs, Lowers Price Target to $342

A federal judge on Tuesday ordered the White House to temporarily lift access restrictions it imposed on the Associated Press, pending the outcome of a lawsuit filed by the news organization.
The restrictions, in place since Feb. 11, had barred AP reporters from Oval Office events, Air Force One flights and other official functions, <a href="https://www.washingtonpost.com/style/media/2025/04/08/associated-press-white-house-ban-lifted/">reported </a>the Washington Post.
The dispute centers on the White House's demand that the AP use the term "Gulf of America" rather than "Gulf of Mexico" in its coverage. The AP declined, citing editorial independence, and filed a lawsuit on Feb. 21 against three Trump administration officials, claiming viewpoint discrimination.
U.S. District Judge Trevor N. McFadden sided with the AP, ruling that the government cannot exclude journalists from press events based on their editorial decisions. While the judge delayed enforcement of the ruling for five days to allow for administrative response, he was clear in his stance.
"If the Government opens its doors to some journalists… it cannot then shut those doors to other journalists because of their viewpoints," McFadden wrote. "The Constitution requires no less."
McFadden found the AP likely to succeed on the merits of its First Amendment claims. Testimony from AP's chief photographer and White House correspondent described how the ban hindered the organization's competitiveness and slowed its news gathering — concerns the judge deemed credible.
He also criticized the administration's "brazen" justification for the ban, rooted in the AP's continued use of "Gulf of Mexico."
AP spokesperson Lauren Easton praised the ruling, calling it a victory for press freedom. "Today's ruling affirms the fundamental right of the press and public to speak freely without government retaliation," she said.
The White House has not issued a response as of publication Tuesday. 
Read Next: <a href="https://www.benzinga.com/government/regulations/25/04/44701436/trump-unleashes-beautiful-clean-coal-policies-as-wall-street-tanks-sp-500-hits-1-year-low"> • Trump Unleashes &#8216;Beautiful Clean Coal&#8217; Policies As Wall Street Tanks, S&amp;P 500 Hits 1-Year Low</a>
Photo: T.Schneider via Shutterstock

Government

Legal

Media

Judge Orders White House To Lift Ban On Associated Press Access

Wells Fargo analyst Michael Brown maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Equal-Weight and lowers the price target from $44 to $38.

Wells Fargo Maintains Equal-Weight on Lazard, Lowers Price Target to $38

Wells Fargo analyst Michael Brown maintains Houlihan Lokey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLI#NYSE">HLI</a>) with a Overweight and lowers the price target from $179 to $170.

Wells Fargo Maintains Overweight on Houlihan Lokey, Lowers Price Target to $170

Wells Fargo analyst Michael Brown maintains Evercore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVR#NYSE">EVR</a>) with a Equal-Weight and lowers the price target from $199 to $180.

Wells Fargo Maintains Equal-Weight on Evercore, Lowers Price Target to $180

Tariffs are once again <a href="https://www.benzinga.com/markets/25/04/44656945/74-billion-wiped-out-since-tariff-declaration-see-how-much-the-billionaires-lost">flooding the headlines</a>. They're in your newsfeed, your inbox, and probably your group chat. The Trump administration's sweeping new import taxes—set to hit everything <a href="https://www.benzinga.com/markets/equities/25/04/44640220/peter-schiff-says-nike-wont-build-factories-in-us-they-will-sell-to-countries-like-china-a-much-better-strategy-amid-trump-tariffs">from electronics to apparel</a>—are back in the spotlight, and of course, billionaire entrepreneur Mark Cuban has thoughts. Spoiler: he's not shy about sharing them.
"If these tariffs stick, it's going to be ugly for Amazon, but incredible for all the American sellers," <a href="https://bsky.app/profile/mcuban.bsky.social/post/3lm4d27pnoc2m">Cuban posted on Bluesky</a>.
That post lit a fuse.
Don't Miss:
<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.55 per share now</a>.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
Cuban's point? Higher costs for imported goods—especially from China—might push consumers toward U.S.-based sellers. It's a perspective rooted in economics: less competition from Chinese sellers, more opportunity for American ones.
But his optimism didn't exactly get a standing ovation.
"I'd love to see data on how many products sold by American sellers are actually made in America?" one user replied.
"The supplies and materials for most products are not in the USA," another added. "Most of the American sellers get their supplies from China. So, the American sellers will also have to raise their prices."
They're not wrong. According to<a href="https://revenuegeeks.com/amazon-seller-statistics/?utm_source=chatgpt.com"> RevenueGeeks</a>, 71% of U.S.-based Amazon sellers source products from China, meaning the tariffs won't just sting foreign companies—they'll squeeze American sellers too.
Trending: If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?
The numbers tell a bigger story. A <a href="https://bsky.app/profile/chelsealawrence.bsky.social/post/3lm4abddyrc2o">SmartScout chart</a> Cuban reposted shows that in major categories like cell phones &amp; accessories, tools &amp; home improvement, and clothing, Chinese sellers dominate—often accounting for more than 50% of the revenue share. In the cell phones category alone, Chinese sellers are pulling in an estimated $8.3 billion out of $9.6 billion in U.S. sales.
So while tariffs might technically give U.S. sellers an edge on paper, in practice, <a href="https://www.benzinga.com/markets/equities/25/04/44655719/trump-tariffs-erode-5-trillion-in-market-cap-in-2-days-as-china-retaliates-jerome-powell-warns-of-inflation">they're just as exposed</a>.
And it's not just about pricing—it's about consumer spending. Bluesky users weren't shy about that either:
"You are assuming people will still have money to spend. If tariffs hold, companies will slow down or implode and individuals will lose jobs."
"People who have been laid off due to [Department of Government Efficiency] or the economic downturn will NOT be buying stuff on Amazon… irrespective of source country."
"Where are the American sellers gonna get the products to sell?"
See Also: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
And one user, in peak 2025 fashion, summed up their stance:
"I am currently on an Amazon-free diet."
The reality is, while Cuban sees this as an inflection point for American sellers, the entire ecosystem—from sourcing to consumer demand—is under pressure. And it's not just theoretical.
As<a href="https://www.wsj.com/livecoverage/trump-tariffs-trade-war-stock-market-04-03-2025/card/the-possible-silver-lining-for-amazon-7zeVy2OvrC5iWwKZ5cSh"> The Wall Street Journal</a> reports, Amazon could take a hit on its private-label products and third-party logistics services. And the end of the de minimis loophole—once allowing duty-free imports under $800—is shaking up fast-fashion players like Shein and Temu, further crowding the e-commerce battlefield.
Amazon could take a $5 billion to $10 billion annual hit to operating profit from rising first-party merchandise costs tied to the tariffs, Goldman Sachs tech analyst Eric Sheridan warned, <a href="https://finance.yahoo.com/news/amazon-could-see-up-to-10-billion-in-profits-go-up-in-smoke-because-of-trump-tariffs-193059725.html">according to Yahoo Finance</a>.&nbsp;
Sure, the tariffs may have been designed to push back against China—but they're also reshaping U.S. retail. And with <a href="https://www.benzinga.com/25/04/44652222/trumps-tariffs-may-shift-us-spending-from-goods-to-services-creating-uncertainty-for-ecommerce-and-advertising-industries-analyst-warns">consumer wallets tightening</a> and supply chains tangled, even Amazon can't algorithm its way out of this one.&nbsp;
Read Next:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>

Personal Finance

Mark Cuban Predicts Tariffs Will Make Things 'Ugly For Amazon, But Incredible for American Sellers' — But Some Point Out They All Source From China

Wells Fargo analyst Michael Brown maintains TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Overweight and lowers the price target from $66 to $52.

Wells Fargo Maintains Overweight on TPG, Lowers Price Target to $52

Wells Fargo analyst Michael Brown maintains Carlyle Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>) with a Equal-Weight and lowers the price target from $48 to $39.

Wells Fargo Maintains Equal-Weight on Carlyle Group, Lowers Price Target to $39

Wells Fargo analyst Michael Brown maintains T. Rowe Price Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>) with a Equal-Weight and lowers the price target from $116 to $98.

TROW

Wells Fargo Maintains Equal-Weight on T. Rowe Price Group, Lowers Price Target to $98

Wells Fargo analyst Michael Brown maintains KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) with a Overweight and lowers the price target from $141 to $120.

Wells Fargo Maintains Overweight on KKR, Lowers Price Target to $120

Wells Fargo analyst Michael Brown maintains Janus Henderson Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>) with a Equal-Weight and lowers the price target from $46 to $36.

Janus Henderson Group plc Ordinary Shares

Wells Fargo Maintains Equal-Weight on Janus Henderson Group, Lowers Price Target to $36

Wells Fargo analyst Michael Brown maintains Invesco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) with a Underweight and lowers the price target from $19.5 to $14.5.

Wells Fargo Maintains Underweight on Invesco, Lowers Price Target to $14.5

Wells Fargo analyst Michael Brown maintains Hamilton Lane (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) with a Equal-Weight and lowers the price target from $152 to $147.

HLNE

Wells Fargo Maintains Equal-Weight on Hamilton Lane, Lowers Price Target to $147

Wells Fargo analyst Michael Brown maintains Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) with a Equal-Weight and lowers the price target from $24 to $20.

Wells Fargo Maintains Equal-Weight on Franklin Resources, Lowers Price Target to $20

Wells Fargo analyst Michael Brown maintains Brookfield Asset Mgmt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAM#NYSE">BAM</a>) with a Underweight and lowers the price target from $50 to $48.

Wells Fargo Maintains Underweight on Brookfield Asset Mgmt, Lowers Price Target to $48

Wells Fargo analyst Michael Brown maintains Bridge Investment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRDG#NYSE">BRDG</a>) with a Equal-Weight and lowers the price target from $11 to $9.

BRDG

Wells Fargo Maintains Equal-Weight on Bridge Investment Group, Lowers Price Target to $9

Press Releases

10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference

U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products

10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Earnings

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

BRKR

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

10x Genomics

Noticias

Últimas noticias sobre 10x Genomics (NASDAQ:TXG) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL